FDA Inspection 1237455 — Cheryl M. Burgess, MD

Cheryl M. Burgess, MD — FEI 3009226944

The FDA completed an inspection of Cheryl M. Burgess, MD on Apr 9, 2024 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 9, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Washington, DC (United States)

Additional Details

Clinical Investigator (CI)